Indalo Targets Idiopathic Pulmonary Fibrosis

Indalo Targets Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis is a highly progressive and life threatening disease affects approximately 130,000 people in the United States.  It’s worse than many cancers.  According to the National Institute of Health, physicians are unsure of the cause, but the... Read more

Evidence Based Innovation 1.0 – Recap

An Event to Connect Investors with Health Care Startups While early-stage startup companies talk a lot about investment, the one thing every young company needs is a customer. Last Tuesday, more than 20 early-stage St. Louis medical and biotech companies got the... Read more
BioTech Selection Committee: Bobby Sandage

BioTech Selection Committee: Bobby Sandage

Spotlight: Selection Committee Member  A Brief Background: Bobby W. Sandage, Jr., Ph.D. has 34 years of experience in the pharmaceutical and biotech industry and was recently appointed President and CEO of Euclises Pharmaceuticals a St. Louis based start-up... Read more